Enanta Pharmaceuticals Inc (ENTA) SEC Filings — 2024
20 SEC filings for Enanta Pharmaceuticals Inc (ENTA) in 2024.
Filings
- Enanta Pharmaceuticals Files 8-K Report — 8-K · Dec 9, 2024
- Enanta Pharmaceuticals Files 2024 Annual Report — 10-K · Nov 27, 2024
- Enanta Pharmaceuticals Files 8-K — 8-K · Nov 25, 2024
- Enanta Pharmaceuticals Inc SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Enanta Pharmaceuticals Inc SC 13G/A Filing — SC 13G/A · Oct 17, 2024
- Enanta Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Aug 7, 2024
- Enanta Pharmaceuticals Files 8-K — 8-K · Aug 5, 2024
- Enanta Pharmaceuticals Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 8, 2024
- Enanta Pharmaceuticals Files 8-K — 8-K · May 6, 2024
- Enanta Pharma Appoints New CMO and Head of Research — 8-K · Mar 12, 2024
- Enanta Pharmaceuticals Inc SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Enanta Pharmaceuticals Inc SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Enanta Pharmaceuticals Files 10-Q for Period Ending December 31, 2023 — 10-Q · Feb 8, 2024
- Enanta Pharma Files 8-K on Financial Results & Operations — 8-K · Feb 7, 2024
- Enanta Pharma Sets March 6 Shareholder Meeting; Proxy Materials Online — DEFA14A · Jan 26, 2024
- Enanta Pharmaceuticals Files DEF 14A with Executive Compensation Details — DEF 14A · Jan 26, 2024
- Farallon Capital Amends Enanta Pharma Stake (SC 13G/A) — SC 13G/A · Jan 26, 2024
- BlackRock Amends Enanta Pharma Stake, Signals Continued Confidence — SC 13G/A · Jan 24, 2024
- State Street Corp. Updates Passive Stake in Enanta Pharma — SC 13G/A · Jan 22, 2024
- Millennium Management Discloses Stake in Enanta Pharma — SC 13G · Jan 11, 2024